Charles Schwab’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.3M Buy
1,182,816
+159,739
+16% +$1.8M ﹤0.01% 1879
2025
Q1
$9.69M Buy
1,023,077
+104,085
+11% +$986K ﹤0.01% 1970
2024
Q4
$10.3M Buy
918,992
+6,597
+0.7% +$74.2K ﹤0.01% 1998
2024
Q3
$25.8M Sell
912,395
-45,742
-5% -$1.29M ﹤0.01% 1554
2024
Q2
$18.3M Buy
958,137
+21,274
+2% +$407K ﹤0.01% 1734
2024
Q1
$30.7M Buy
936,863
+42,591
+5% +$1.4M 0.01% 1346
2023
Q4
$29.5M Buy
894,272
+35,276
+4% +$1.17M 0.01% 1344
2023
Q3
$23.4M Buy
858,996
+107,963
+14% +$2.94M 0.01% 1404
2023
Q2
$22.8M Buy
751,033
+83,517
+13% +$2.53M 0.01% 1403
2023
Q1
$21.7M Sell
667,516
-40,906
-6% -$1.33M 0.01% 1409
2022
Q4
$19.9M Buy
708,422
+86,798
+14% +$2.44M 0.01% 1449
2022
Q3
$22.3M Buy
621,624
+34,312
+6% +$1.23M 0.01% 1287
2022
Q2
$18M Sell
587,312
-678
-0.1% -$20.8K 0.01% 1481
2022
Q1
$19M Buy
587,990
+15,177
+3% +$490K 0.01% 1589
2021
Q4
$15.9M Buy
572,813
+25,530
+5% +$706K ﹤0.01% 1749
2021
Q3
$17M Buy
547,283
+5,672
+1% +$176K 0.01% 1703
2021
Q2
$11.4M Buy
541,611
+13,225
+3% +$279K ﹤0.01% 1924
2021
Q1
$10.7M Buy
528,386
+16,994
+3% +$343K ﹤0.01% 1925
2020
Q4
$8.2M Buy
511,392
+7,308
+1% +$117K ﹤0.01% 1971
2020
Q3
$6.26M Buy
504,084
+1,734
+0.3% +$21.5K ﹤0.01% 1962
2020
Q2
$3.58M Buy
502,350
+30,224
+6% +$215K ﹤0.01% 2186
2020
Q1
$2.56M Buy
472,126
+12,218
+3% +$66.4K ﹤0.01% 2170
2019
Q4
$4.16M Buy
459,908
+10,309
+2% +$93.3K ﹤0.01% 2115
2019
Q3
$3.23M Buy
449,599
+21,503
+5% +$155K ﹤0.01% 2187
2019
Q2
$3.4M Buy
428,096
+24,661
+6% +$196K ﹤0.01% 2156
2019
Q1
$5.08M Buy
403,435
+18,563
+5% +$234K ﹤0.01% 1975
2018
Q4
$7.68M Sell
384,872
-574
-0.1% -$11.5K 0.01% 1637
2018
Q3
$10.9M Buy
385,446
+45,852
+14% +$1.3M 0.01% 1575
2018
Q2
$7.15M Buy
339,594
+27,390
+9% +$577K 0.01% 1814
2018
Q1
$4.45M Buy
312,204
+14,749
+5% +$210K ﹤0.01% 2004
2017
Q4
$3.66M Buy
297,455
+52,696
+22% +$648K ﹤0.01% 2071
2017
Q3
$4.36M Buy
244,759
+56,780
+30% +$1.01M ﹤0.01% 1945
2017
Q2
$4.77M Buy
187,979
+124,799
+198% +$3.16M ﹤0.01% 1844
2017
Q1
$1.41M Buy
63,180
+3,591
+6% +$80.1K ﹤0.01% 2315
2016
Q4
$882K Buy
59,589
+3,234
+6% +$47.9K ﹤0.01% 2472
2016
Q3
$1.39M Buy
56,355
+13,571
+32% +$334K ﹤0.01% 2295
2016
Q2
$822K Buy
42,784
+504
+1% +$9.68K ﹤0.01% 2409
2016
Q1
$447K Buy
42,280
+11,912
+39% +$126K ﹤0.01% 2620
2015
Q4
$368K Buy
30,368
+16,880
+125% +$205K ﹤0.01% 2780
2015
Q3
$216K Buy
+13,488
New +$216K ﹤0.01% 2937